Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching

Cell Death and Differentiation

Volumn 11, Issue SUPPL. 2, 2004, Pages

  Rae, C ^a   MacEwan, David J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Cancer cells; Cytokine; Receptor; Tumour necrosis factor

Indexed keywords

CYCLOHEXIMIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL; MITOSIS INHIBITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; LEUKEMIA; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12744260128     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401494     Document Type: Article

References (58)

1. Old LJ (1985) Tumor necrosis factor (TNF). Science 230: 630-632
2. Carswell EA, Old U, Kassel RL, Green S, Fiore N and Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl. Acad. Sci. USA 72: 3666-3670
3. Fiers W (1991) Tumor-necrosis-factor - characterization at the molecular, cellular and in vivo level. FEBS Lett. 285: 199-212
4. Kelley J (1990) Cytokines of the lung. Am. Rev. Respir. Dis. 141: 765-788
5. Vandenabeele P, Declercq W, Beyaert R and Fiers W (1995) 2 Tumor-necrosis-factor receptors - structure and function. Trends Cell Biol. 5: 392-399
6. MacEwan DJ (2002) TNF receptor subtype signaling. Differences and cellular consequences. Cell Signal. 14: 477-492
7. Locksley RM, Killeen N and Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501
8. Baxter GT, Kuo RC, Jupp OJ, Vandenabeele P and MacEwan DJ (1999) Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem. 274: 9539-9547
9. Tsuru K, Horikawa T, Budiyanto A, Hikita I, Ueda M and Ichihashi M (2001) Low-dose ultraviolet b radiation synergizes with TNF-α to induce apoptosis of keratinocytes. J. Dermatol. Sci. 26: 209-216
10. Kuo KW, Hsu SH, Li YP, Lin WL, Liu LF, Chang LC, Lin CC, Lin GN and Sheu HM (2000) Anticancer activity evaluation of the solanum glycoalkaloid solamargine - triggering apoptosis in human hepatoma cells. Biochem. Pharmacol. 60: 1865-1873
11. Messmer UK, Briner VA and Pfeilschifter J (2000) Basic fibroblast growth factor selectively enhances TNF-α induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J. Am. Soc. Nephrol. 11: 2199-2211
12. Hsu SH, Tsai TR, Lin CN, Yen MH and Kuo KW (1996) Solamargine purified from solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. Biochem. Biophys. Res. Commun. 229: 1-5
13. Hannun YA (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89: 1845-1853
14. Wyllie AH (1993) Apoptosis (the 1992 Rose, Frank memorial lecture. Br. J. Cancer 67: 205-208
15. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM and Venkatachalam MA (1999) Apoptosis: definition, mechansisms, and relevance to disease. Am. J. Dis. 107: 489-506
16. Tsushima H, Imaizumi Y, Imanishi D, Fuchigami K and Tomonaga I (1999) Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-α and potentiates apoptotic death. Exp. Hematol. 27: 433-440
17. Berger AC, Alexander HR, Wu PC, Tang GQ, Gnant MFX, Mixon A, Turner ES and Libutti SK (2000) Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte-activating polypeptide II (EMAP-II). Cytokine 12: 992-1000
18. Rusten LS and Jacobsen SEW (1995) Tumor-necrosis-factor (TNF)-α directly inhibits human erythropoiesis in-vitro - role of p55 and p75 TNF receptors. Blood 85: 989-996
19. Rebel VI, Hartnett S, Hill GR, Lazo-Kallanian SB, Ferrara JLM and Sieff CA (1999) Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J. Exp. Med. 190: 1493-1503
20. Delwel R, Vanbuitenen C, Lowenberg B and Touw I (1992) Involvement of tumor-necrosis-factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid-leukemia blasts in vitro. Blood 80: 1798-1803
21. Hu XT, Tang MQ, Fisher AB, Olashaw N and Zuckerman KS (1999) TNF-α-induced growth suppression of CD34(+) myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-κ B activation. J. Immunol. 163: 3106-3115
22. Carter A, Haddad N, Draxler I, Israeli E, Raz B and Rowe JM (1996) Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. Br. J. Haematol. 92: 116-126
23. Berkova N, Lemay A, Korobko V, Shingarova L, Sagaidak L and Goupil S (1999) Tumor necrosis factor mutants with selective cylotoxic activity. Cancer Detect. Prev. 23: 1-7
24. Vanostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P and Fiers W (1993) Human TNF mutants with selective activity on the p55 receptor. Nature 361: 266-269
25. Martinon F, Holler N, Richard C and Tschopp J (2000) Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 468: 134-136
26. Avanzi GC, Porcu P, Brizzi MF, Ghigo D, Bosia A and Pegoraro L (1991) Interleukin 3-dependent proliferation of the human MO-7e cell-line is supported by discrete activation of late G1 genes. Cancer Res. 51: 1741-1743
27. Williams MA, Newland AC and Kelsey SM (2000) Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets. Leuk. Res. 24: 317-330
28. Hassan HT and Zander AR (1997) Haematopoietic cytokines in the biology and treatment of acute myeloid leukaemia: perspectives and controversies. Oncol. Rep. 4: 1141-1149
29. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A and Takaku F (1989) Establishment and characterization of a unique human cell-line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140: 323-334
30. Klampfer L, Zhang J and Nimer SD (1999) GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of bcl-2 and mcl-1. Cytokine 11: 849-855
31. Murray J, Barbara JAJ, Dunkley SA, Lopez AF, Vanostade X, Condliffe AM, Dransfield I, Haslett C and Chilvers ER (1997) Regulation of neutrophil apoptosis by tumor necrosis factor-α: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783
32. Wong CK, Zhang JP, Lam CWK, Ho CY and Hjelm NM (1999) Opposing effects of sodium salicylate and haematopoietic cytokines IL-3, IL-5 and GM-CSF on mitogen-activated protein kinases and apoptosis of EOL-1 cells. Immunol. Invest. 28: 365-379
33. Quentmeier H, Dirks WG, Fleckenstein D, Zaborski M and Drexler HG (2000) Tumor necrosis factor-α-induced proliferation requires synthesis of granulo-cyte-macrophage colony-stimulating factor. Exp. Hematol. 28: 1008-1015
34. Wadhwa M, Dilger P, Meager A, Walker B, Gainesdas R and Thorpe R (1996) IL-4 and TNF-α-mediated proliferation of the human megakaryocytic line M-O7e is regulated by induced autocrine production of GM-CSF. Cytokine 8: 900-909
35. Horie T, Dobashi K, Iizuka K, Yoshii A, Shimizu Y, Nakazawa T and Mori M (1999) Interferon-gamma rescues TNF-α-induced apoptosis mediated by up-regulation of TNFR2 on EOL-1 cells. Exp. Hematol. 27: 512-519
36. Loetscher H, Stueber D, Banner D, Mackay F and Lesslauer W (1993) Human tumor-necrosis-factor-α (TNF-α) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268: 26350-26357
37. Yui J, Hemmings D, Garcialloret M and Guilbert LJ (1996) Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol. Reprod 55: 400-409
38. Jelkmann W and Hellwig-Buergel T (1999) Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production. Exp. Hematol. 27: 224-228
39. McFarlane SM, Pashmi G, Connell MC, Littlejohn AF, Tucker SJ, Vandenabeele P and MacEwan DJ (2002) Differential activation of nuclear factor-κB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett. 515: 119-126
40. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K and Scheurich P (1995) The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80 kDa tumor-necrosis-factor receptor. Cell 83: 793-802
41. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV and Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367
42. Funk JO, Walczak H, Voigtlander C, Berchtold S, Baumeister T, Rauch P, Rossner S, Steinkasserer A, Schuler G and Lutz MB (2000) Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1. J. Immunol. 165: 4792-4796
43. Lung HL, Leung KN, Stadlin A, Ma CM and Tsang D (2001) Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes. Life Sci. 68: 2081-2091
44. Sipe KJ, Dantzer R, Kelley KW and Weyhenmeyer JA (1998) Expression of the 75 kDa TNF receptor and its role in contact-mediated neuronal cell death. Mol. Brain Res. 62: 111-121
45. Bigda J, Beletsky I, Brakebusch C, Varfolomeev Y, Engelmann H, Bigda J, Holtmann H and Wallach D (1994) Dual role of the p75 tumor-necrosis-factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180: 445-460
46. Medvedev AE, Sundan A and Espevik T (1994) Involvement of the tumor-necrosis-factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur. J. Immunol. 24: 2842-2849
47. Jupp OJ, McFarlane SM, Anderson HM, Littlejohn AF, Mohamed AAA, MacKay RH, Vandenabeele P and MacEwan DJ (2001) Type II tumour necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 359: 525-535
48. Vandenabeele P, Declerq W, Vercammen D, Van de Craen M, Grooten J, Loetscher H, Brockhaus M, Lesslauer W and Fiers W (1992) Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J. Exp. Med. 176: 1015
49. Haridas V, Damay BG, Natarajan K, Heller R and Aggarwal BB (1998) Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol. 160: 3152-3162
50. Tartaglia LA, Pennica D and Goeddel DV (1993) Ligand passing - the 75-kDa tumor-necrosis-factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268: 18542-18548
51. Pinckard JK, Sheehan KCF and Schreiber RD (1997) Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272: 10784-10789
52. Wajant H and Scheurich P (2001) Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Intl. J. Biochem. Cell Biol. 33: 19-32
53. Fotin-Mleczek M, Henkler F, Samel D, Reichwein M, Hausser A, Parmryd I, Scheurich P, Schmid JA and Wajant H (2002) Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell. Sci. 115: 2757-2770
54. Krippner-Heidenreich A, Tubing F, Bryde S, Willi S, Zimmermann G and Scheurich P (2002) Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. J. Biol. Chem. 277: 44155-44163
55. Liu RY, Fan C, Olashaw NE, Wang X and Zuckerman KS (1999) Tumor necrosis factor-α-induced proliferation of human MO7e leukemic cells occurs via activation of nuclear factor κB transcription factor. J. Biol. Chem. 274: 13877-13885
56. Duffey DC, Crowl-Bancroft CV, Chen Z, Ondrey FG, Nejad-Sattari M, Dong G and Van Waes C (2000) Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death. Br. J. Cancer 83: 1367-1374
57. Schulz A and Bauer G (2000) Selective effect of tumor necrosis factor on transformed versus nontransformed cells: nonselective signal recognition but differential target cell response. Anticancer Res. 20: 3435-3442
58. Jupp OJ, Vandenabeele P and MacEwan DJ (2003) Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes. Biochem. J. 374: 453-461